Cambridge Investment Research Advisors
EVH icon

Cambridge Investment Research Advisors’s Evolent Health EVH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,644
Closed -$287K – 1751
2016
Q3 		$287K Buy
+11,644
New +$272K 0.01% 1327

Other funds holding EVH

PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Cambridge Investment Research Advisors's EVH Position: Q4 2016 in Review

Cambridge Investment Research Advisors sold out of Evolent Health (EVH) in Q4 2016, closing a stake of 11,644 shares — an estimated $287K sold.

Cambridge Investment Research Advisors first reported a position in EVH in Q3 2016 and held it in 1 quarter. The position peaked at $287K in Q3 2016. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

  • Cambridge Investment Research Advisors reported no remaining Evolent Health position as of Q4 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,644 Evolent Health shares in Q4 2016, an estimated $287K.
  • Cambridge Investment Research Advisors first reported a position in Evolent Health in Q3 2016 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Evolent Health position peaked at $287K in Q3 2016.
  • 118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.